CIK: 0001602263
申告総資産額
$3.8億
| # | ティッカー | 発行体 | 資産子分類 | 比率 | 比率変動 | 持株数変化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ASND | Ascendis Pharma A/S | 株式-その他 | 18.30% | -8.61% | EXIT | |
| 2 | SWAVUSD | Shockwave Medical INC | 株式-その他 | 16.22% | -4.03% | — | |
| 3 | BHVN | Biohaven Ltd. | 株式-その他 | 13.29% | -4.69% | -15.39% | |
| 4 | ✓ | Obseva SA | 株式-その他 | 8.03% | -5.57% | — | |
| 5 | AXSM | Axsome Therapeutics INC | 株式-ヘルスケア | 7.25% | +14.53% | +56.12% | |
| 6 | RARXEUR | Ra Pharmaceuticals INC | 株式-その他 | 6.42% | -6.10% | EXIT | |
| 7 | ZGNXEUR | Zogenix INC | 株式-その他 | 5.45% | — | — | |
| 8 | 1T7 | Tricida INC | 株式-その他 | 5.33% | -1.40% | EXIT | |
| 9 | BCRX | Biocryst Pharmaceuticals INC | 株式-その他 | 3.43% | -3.14% | EXIT | |
| 10 | CNST | Constellation Pharmaceutical | 株式-その他 | 2.81% | +16.85% | — | |
| 11 | 4XC1 | Kalvista Pharmaceuticals INC | 株式-その他 | 2.63% | +0.05% | -34.28% | |
| 12 | KNSA | Kiniksa Pharmaceuticals International, plc | 株式-その他 | 2.60% | -1.75% | EXIT | |
| 13 | SPRO | Spero Therapeutics INC | 株式-その他 | 1.72% | -0.72% | — | |
| 14 | PTGX | Protagonist Therapeutics INC | 株式-その他 | 1.63% | -1.89% | +57.27% | |
| 15 | LJPC | La Jolla Pharmaceutical Co | 株式-その他 | 1.51% | -1.74% | EXIT | |
| 16 | MIST | Milestone Pharmaceuticals In | 株式-その他 | 1.27% | -0.43% | — | |
| 17 | MRNSUSD | Marinus Pharmaceuticals INC | 株式-その他 | 0.97% | -0.02% | — | |
| 18 | BLPHEUR | Bellerophon Therapeutics INC | 株式-その他 | 0.79% | -0.70% | — | |
| 19 | KDMN | Kadmon Holdings INC | 株式-その他 | 0.16% | — | -69.58% | |
| 20 | ✓ | Gemphire Therapeutics INC | 株式-その他 | 0.12% | — | -8.22% | |
| 21 | PTIEUR | Proteostasis Therapeutics In | 株式-その他 | 0.04% | -0.04% | EXIT |
| # | ティッカー | 発行体 | 比率変動 | 持株数変化 | アクション |
|---|---|---|---|---|---|
| 1 | SWAVUSD | Shockwave Medical INC | +7.4% | — | 変化なし |
| 2 | AXSM | Axsome Therapeutics INC | +4.9% | +56.12% | 増加 |
| 3 | RARXEUR | Ra Pharmaceuticals INC | +2.3% | +7.06% | 増加 |
| 4 | ASND | Ascendis Pharma A/S | +0.9% | — | 変化なし |
| 5 | LJPC | La Jolla Pharmaceutical Co | +0.8% | +39.50% | 増加 |
| 6 | PTGX | Protagonist Therapeutics INC | +0.6% | +57.27% | 増加 |
| 7 | MRNSUSD | Marinus Pharmaceuticals INC | +0.1% | — | 変化なし |
| 8 | BLPHEUR | Bellerophon Therapeutics INC | 0% | — | 変化なし |
| 9 | ✓ | Gemphire Therapeutics INC | -0.1% | -8.22% | 減少 |
| 10 | SPRO | Spero Therapeutics INC | -0.1% | — | 変化なし |
| 11 | CNST | Constellation Pharmaceutical | -0.1% | — | 変化なし |
| 12 | PTIEUR | Proteostasis Therapeutics In | -0.1% | -69.39% | 減少 |
| 13 | ZGNXEUR | Zogenix INC | -0.4% | — | 変化なし |
| 14 | ✓ | Obseva SA | -0.4% | — | 変化なし |
| 15 | KDMN | Kadmon Holdings INC | -0.5% | -69.58% | 減少 |
| 16 | KNSA | Kiniksa Pharmaceuticals International, plc | -0.8% | -4.72% | 減少 |
| 17 | 4XC1 | Kalvista Pharmaceuticals INC | -2.2% | -34.28% | 減少 |
| 18 | BHVN | Biohaven Ltd. | -3.9% | -15.39% | 減少 |
| 19 | BCRX | Biocryst Pharmaceuticals INC | -4.3% | -11.53% | 減少 |
| 20 | 1T7 | Tricida INC | -5.6% | -55.47% | 減少 |
| 21 | MIST | Milestone Pharmaceuticals In | — | NEW | 新規購入 |
| 22 | ORTXUSD | Orchard Therapeutics PLC | — | EXIT | 全売却 |